Yeah, I feel fairly certain that the Alz results will be strong, based on the admittedly-inconclusive results of the various other trials. The timeline of when the new results are released, or not released, is akin to astrology, in my opinion. People are attempting to fill a vacuum of information with rationalizations, each side attempting to read tea leaves. To quote an oft-used phrase here, “this is nonsense.”
Exactly. We had excellent results from the "P3" AVATAR trial earlier this year for adult Rett. Once the data from the Excellence Pediatric rett trial is complete, I fully expect Anavex to submit a NDA...and for us to receive FDA approval no later than September, 2023.
That scenario alone should increase our MC to $5 Billion...which would give us a $50 share price.
I sleep very well knowing that Anavex has a full pipeline.
Meanwhile, we only have 3 more weeks before the AD results are announced!
Big day finally coming. Buckle up...should be a very exciting day!!!
Market Data 
Markets 
AI
